Genenta Science nominates Anthony Marucci for election to its Board as Independent Director and appoints Richard Slansky as CFO
– ITALY, Milan – Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer, today announced the appointment of Richard Slansky is as CFO and the nomination of Anthony Marucci for election to its Board as an Independent Director, at the next AGM on May 20, 2021.…